Apricus Biosciences (APRI) in Focus: Stock Gains 10.1% - Tale of the Tape
Apricus Biosciences, Inc. ( APRI ) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.59 to $1.75 in the past one-month time frame.
The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate hasn't been in a trend either. Thursday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Apricus currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked stock in the same space is Cardiome Pharma Corp. ( CRME ) sporting a Zacks Rank #1 (Strong Buy).